Clinician Article
Recommendations on screening for prostate cancer with the prostate-specific antigen test.
PMID: 25349003
-
Public HealthRelevance - 7/7
Newsworthiness - 7/7 -
Family Medicine (FM)/General Practice (GP)Relevance - 7/7
Newsworthiness - 5/7 -
General Internal Medicine-Primary Care(US)Relevance - 7/7
Newsworthiness - 5/7 -
Oncology - GeneralRelevance - 6/7
Newsworthiness - 5/7 -
Oncology - GenitourinaryRelevance - 6/7
Newsworthiness - 5/7 -
Surgery - UrologyRelevance - 6/7
Newsworthiness - 4/7
Abstract
This item does not have an abstract.
Clinical Comments
General Internal Medicine-Primary Care(US)
It's a little bit depressing to see that this data has been around for at least 4 years or so and still physicians use PSA to screen...apparently the 10 year gap between publishing and practice change is still current...
Oncology - Genitourinary
Good review.
Public Health
Not recommending PSa even to patients with BPH symptoms is a novel idea and might need further study before full implementation.
Surgery - Urology
This is an additional recommendation document to add strength to the need for a clear understanding between the clinician and the patient with regards to individual screening. The improvement in tools of screening for prostate cancer, e.g. 3T MRI, will help in going forwards in this forward changing field with more productive outcome of utilizing tools available.
Register for free access to all Professional content
RegisterOur Content
About
Support for the Portal is largely provided by the Labarge Optimal Aging Initiative. AGE-WELL is a contributing partner. Help us to continue to provide direct and easy access to evidence-based information on health and social conditions to help you stay healthy, active and engaged as you grow older. Donate Today.
